ArticleCancers2024

Sequential Endoluminal Doxorubicin and Gemcitabine Alternating Weekly with Sequential Mitomycin and Docetaxel for Recurrent Non-Muscle Invasive Urothelial Carcinoma.

Ian M McElree et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.